105 related articles for article (PubMed ID: 8574641)
1. Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDMA) and other substituted amphetamines in cultured fetal raphe neurons: further evidence for calcium-independent mechanisms of release.
Wichems CH; Hollingsworth CK; Bennett BA
Brain Res; 1995 Oct; 695(1):10-8. PubMed ID: 8574641
[TBL] [Abstract][Full Text] [Related]
2. The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.
Berger UV; Gu XF; Azmitia EC
Eur J Pharmacol; 1992 May; 215(2-3):153-60. PubMed ID: 1356787
[TBL] [Abstract][Full Text] [Related]
3. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.
Crespi D; Mennini T; Gobbi M
Br J Pharmacol; 1997 Aug; 121(8):1735-43. PubMed ID: 9283711
[TBL] [Abstract][Full Text] [Related]
4. p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo.
Series HG; Cowen PJ; Sharp T
Psychopharmacology (Berl); 1994 Dec; 116(4):508-14. PubMed ID: 7535469
[TBL] [Abstract][Full Text] [Related]
5. MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for Ca2(+)-dependent toxicity linked to release.
Azmitia EC; Murphy RB; Whitaker-Azmitia PM
Brain Res; 1990 Feb; 510(1):97-103. PubMed ID: 1969761
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the translocation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA/ecstasy) in synaptosomes: evidence for a presynaptic localization involving the serotonin transporter (SERT).
Kramer HK; Poblete JC; Azmitia EC
Neuropsychopharmacology; 1998 Oct; 19(4):265-77. PubMed ID: 9718590
[TBL] [Abstract][Full Text] [Related]
7. MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin.
Sprouse JS; Bradberry CW; Roth RH; Aghajanian GK
Eur J Pharmacol; 1989 Aug; 167(3):375-83. PubMed ID: 2572435
[TBL] [Abstract][Full Text] [Related]
8. Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats.
Kehne JH; McCloskey TC; Taylor VL; Black CK; Fadayel GM; Schmidt CJ
J Pharmacol Exp Ther; 1992 Jan; 260(1):78-89. PubMed ID: 1731054
[TBL] [Abstract][Full Text] [Related]
9. Effect of glucoprivation on serotonin neurotoxicity induced by substituted amphetamines.
Yuan J; Cord BJ; McCann UD; Callahan BT; Ricaurte GA
J Pharmacol Exp Ther; 2002 Nov; 303(2):831-9. PubMed ID: 12388670
[TBL] [Abstract][Full Text] [Related]
10. 3,4-Methylenedioxymethamphetamine-induced release of serotonin and inhibition of dorsal raphe cell firing: potentiation by L-tryptophan.
Sprouse JS; Bradberry CW; Roth RH; Aghajanian GK
Eur J Pharmacol; 1990 Mar; 178(3):313-20. PubMed ID: 1971220
[TBL] [Abstract][Full Text] [Related]
11. Direct effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphé nucleus slices.
Iravani MM; Asari D; Patel J; Wieczorek WJ; Kruk ZL
Synapse; 2000 Jun; 36(4):275-85. PubMed ID: 10819905
[TBL] [Abstract][Full Text] [Related]
12. An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats.
Connor TJ; Kelly JP; Leonard BE
Immunopharmacology; 2000 Mar; 46(3):223-35. PubMed ID: 10741902
[TBL] [Abstract][Full Text] [Related]
13. Tolerance to 3,4-methylenedioxymethamphetamine is associated with impaired serotonin release.
Jones K; Brennan KA; Colussi-Mas J; Schenk S
Addict Biol; 2010 Jul; 15(3):289-98. PubMed ID: 20477756
[TBL] [Abstract][Full Text] [Related]
14. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
Callaway CW; Wing LL; Geyer MA
J Pharmacol Exp Ther; 1990 Aug; 254(2):456-64. PubMed ID: 1974635
[TBL] [Abstract][Full Text] [Related]
15. Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons.
Gu XF; Azmitia EC
Eur J Pharmacol; 1993 Apr; 235(1):51-7. PubMed ID: 8100196
[TBL] [Abstract][Full Text] [Related]
16. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
Colado MI; Murray TK; Green AR
Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
[TBL] [Abstract][Full Text] [Related]
17. Altered prolactin response to M-chlorophenylpiperazine in monkeys previously treated with 3,4-methylenedioxymethamphetamine (MDMA) or fenfluramine.
Hatzidimitriou G; Tsai EH; McCann UD; Ricaurte GA
Synapse; 2002 Apr; 44(1):51-7. PubMed ID: 11842446
[TBL] [Abstract][Full Text] [Related]
18. Long-term impairment of anterograde axonal transport along fiber projections originating in the rostral raphe nuclei after treatment with fenfluramine or methylenedioxymethamphetamine.
Callahan BT; Cord BJ; Ricaurte GA
Synapse; 2001 May; 40(2):113-21. PubMed ID: 11252022
[TBL] [Abstract][Full Text] [Related]
19. Sustained exposure to 3,4-methylenedioxymethamphetamine induces the augmentation of exocytotic serotonin release in rat organotypic raphe slice cultures.
Nagayasu K; Kitaichi M; Shirakawa H; Nakagawa T; Kaneko S
J Pharmacol Sci; 2010; 113(2):197-201. PubMed ID: 20484864
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of serotonin release by sustained exposure to MDMA and methamphetamine in rat organotypic mesencephalic slice cultures containing raphe serotonergic neurons.
Higuchi M; Suzuki Y; Yatani Y; Kitagawa Y; Nagayasu K; Shirakawa H; Nakagawa T; Kaneko S
J Neurochem; 2008 Sep; 106(6):2410-20. PubMed ID: 18662325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]